29.12.2021 Views

Diagnostic ultrasound ( PDFDrive )

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 31 Chromosomal Abnormalities 1089

10

Trisomy 13

Trisomy 18

Trisomy 21

1.0

Risk (%)

0.1

Turner

Triploidy

0.01

20 25 30 35 40 45

Maternal age (yr)

FIG. 31.1 Maternal Age–Related Risk for Chromosomal Abnormalities.

5000 and 1 in 10,000, respectively. 8 he frequency of aneuploidy

is higher earlier in gestation because of the fetal loss rate associated

with chromosomal abnormalities as gestation progresses. Fetal

death with trisomy 21 between the irst or second trimester and

birth is 30% and 20%, respectively. Fetal death between the irst

trimester and birth with trisomies 18 and 13 is approximately

80%. 6,9

FIRST-TRIMESTER SCREENING

FOR ANEUPLOIDY

First-trimester screening for aneuploidy that incorporates

ultrasound provides a patient-speciic numeric risk estimate of

trisomy 21, 18 and 13. It may also be a clue for other chromosomal

conditions. 10 Most pregnancies are normal, so most women can

be reassured early in gestation that their risk of aneuploidy is

low. Others may ind that the risk estimate is high enough that

to undergo a secondary screening with cell-free DNA or

diagnostic testing (chorionic villous sampling) to obtain a

karyotype or microarray analysis. If the results are abnormal,

the patient has time to obtain additional information and explore

resources that are available before making a decision about

continuing or terminating a pregnancy. he decision to terminate

can be made with privacy and at a time in pregnancy when safe

methods of pregnancy interruption are available. 11

Nuchal Translucency and Trisomy 21

In 1866, Dr. Langdon Down reported a classiication of individuals

with developmental delay who had similar physical characteristics.

He described the skin as “deicient in elasticity, giving the appearance

of being too large of the body.” 12 Fetuses with trisomy 21

as well as other aneuploidies oten have excess luid in the

subcutaneous tissue behind the fetal neck (Fig. 31.2A, Video

31.1). Sonographically, this appears as an echolucent luid

collection between the sot tissue over the cervical spine and an

echogenic line representing the skin edge. his luid space is

called the nuchal translucency (NT) 13 (Fig. 31.2B). he lucency

is thought to represent mesenchymal edema and is oten associated

with distended jugular lymphatics (Fig. 31. 2C). he prevailing

theory suggests an alteration in lymphangiogenesis and delayed

lymphatic development. Other possible causes include cardiac

failure and abnormal extracellular matrix, but these do not explain

the localized and transient nature of the NT. Most likely, the

cause is a complex interaction of factors. 14 NT normally increases

with advancing gestational age, and therefore the measurement

is compared to crown-rump length (CRL, Fig. 31.2D). An NT

greater than 95% for CRL is considered thickened. An NT greater

than 99% does not change signiicantly with CRL and is approximately

3.5 mm 15 (Fig. 31.2E).

In 1992, Nicolaides et al. 13 reported that an NT of 3 mm or

greater in the irst trimester was associated with a 35% risk of

chromosomal abnormality. he association between chromosome

anomalies and a thickened NT was subsequently conirmed in

a large, prospective multicenter trial of 20,804 pregnancies. he

risk of trisomy 21 can be calculated by multiplying the a priori

(presumptive) risk by a likelihood ratio derived from the degree

of deviation in NT from the expected NT. his methodology, in

conjunction with a risk cutof of 1 in 300, resulted in the identiication

of 80% of fetuses with trisomy 21, with a false-positive rate

(FPR) of 5%. 16 Snijders et al. 17 evaluated the use of NT and

maternal age to detect trisomy 21 in a multicenter trial that

included 22 diferent sites and 306 trained sonographers. Using

a threshold of 1 in 300, the sensitivity for the detection of trisomy

21 was 82% for an FPR of 8%. If the FPR was set at 5%, the

sensitivity for the detection of trisomy 21 was 77%.

Serum Biochemical Markers

A variety of serum biochemical markers have diferent concentrations

in pregnancies with trisomy 21 compared with euploid

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!